16 August 2024
Aimed at Liver
Artificial intelligence-based measurement (AIM) tool for scoring findings in liver biopsies from patients with a disease called metabolic dysfunction-associated steatohepatitis (MASH). AIM assists in arriving at a consensus when pathologists' interpretations vary and enables more reproducible clinical trial outcome scoring
Read the published research article here
Written by
- Image from work by Janani S. Iyer, Dinkar Juyal, Quang Le and Zahil Shanis, and colleagues
- PathAI, Boston, MA, USA
- Image originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)
- Published in Nature Medicine, August 2024
Search The Archive
Submit An Image
Like us on Facebook
Follow on Twitter
Follow on Tumblr
Follow on Instagram
What is BPoD?
BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.